22/05/2024  18:14:28 Var. - Volume Denaro- Lettera- Capitalizzazione di mercato Dividend Y. Rapporto P/E
188.00EUR - -
Fatturato: -
-Quantità in denaro: - -Quantità in lettera: - 15.02 bill.EUR - -

Descrizione business

Laboratory Corporation of America® Holdings, an S& P 500 company, is the world's leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people's health by delivering the combination of world-class diagnostics, drug development and knowledge services.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Adam Schechter
Consiglio di amministrazione
Glenn Eisenberg, Amy Summy, Anita Graham, Brian Caveney, Jon DiVincenzo, Lance Berberian, Mark Schroeder , Megan Bailey, Sandra van der Vaart, J.D., Peter J. Wilkinson
Consiglio di sorveglianza
Adam H. Schechter, Kerrii B. Anderson, Jean-Luc Bélingard, Jeffrey A. Davis, D. Gary Gilliland M.D., Ph.D., Kirsten Kliphouse, Garheng Kong M.D., Ph.D., Peter M. Neupert, Richelle P. Parham, Paul B. Rothman, M. D., Kathryn E. Wengel, R. Sanders Williams, M.D.
 

Dati aziendali

Name: Laboratory Corporation of America Holdings
Indirizzo: 531 South Spring Street,Burlington, North Carolina 27215, USA
Telefono: +1-336-229-1127
Fax: +1-336-436-1569
E-mail: -
Internet: https://www.labcorp.com/
Industria: Healthcare
Settore: Medical Products
Sub settore: Advanced Medical Devices
Fine dell'anno finanziario: 31/12
Flottante libero: 78.40%
Data dell'IPO: -

Rapporti con gli investitori

Name: Chas Cook
IR telefono: +1-336-436-5076
IR Fax: 336-436-1569
IR e-mail: investor@labcorp.com

Company calendar

CW 24 | 12/06/2024 Dividend Payment